Abstract
For nonsurgical and surgically high risk patients with valvular heart disease, transcatheter valve repair and replacement has become a rapidly growing option. Initially, aortic valve stenosis was considered for transcatheter treatment because of easy access, simple anatomy, straightforward physiology, and most important with calcific stenosis a secure landing spot for transcatheter valve anchorage. However, with transcatheter valve technology improving rapidly, nonsurgical and high-risk surgical patients with mitral regurgitation now have the option to have a transcatheter mitral valve repair.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feldman T, Young A. Percutaneous approach to valve repair for mitral regurgitation. J Am Coll Cardiol. 2014;63:2057–68.
Glower D, Ailawadi G, Argenziano M, Mack M, Trento A, Wang A, et al. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S60–3.
Banai S, Verheye S, Cheung A, Schwartz M, Marko A, Lane R, et al. Transpical mitral implantation of the Tiara bioprothesis: pre-clinical results. JACC Cardiovasc Interv. 2014;7(2):154–62.
Cheung A, Webb JG, Wong DR, Ye J, Masson JB, Carere RG, et al. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87(3):e18–20.
Anyanwu AC, Adams DH. Transcatheter mitral valve replacement: the next revolution? J Am Coll Cardiol. 2014;64(17):1820–4.
Schymik G, Würth A, Bramlage P, Herbinger T, Heimeshoff M, Pilz L, et al. Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis. Circ Cardiovasc Interv. 2014;8(1)
Dvir D. Update from the global valve-in-valve registry, TCT Meeting, Miami 2012.
Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation. Circulation. 2014;130(19):1712–22.
De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400–9.
Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, et al. Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64(17):1814–9.
Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, et al. Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention. 2014;10(Suppl U):U120–8.
Lutter G, Lozonschi L, Ebner A, et al. First-in-human off-pump transcatheter mitral valve replacement. J Am Coll Cardiol Interv. 2014;7(9):1077–8.
Lutter G, Pokorny S, Frank D, Cremer J, Lozonschi L. Transapical mitral valve implantation: the Lutter valve. Heart Lung Vessel. 2013;5(4):201–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cheung, A., Lichtenstein, K. (2016). Barriers to Transcatheter Mitral Valve Replacement. In: Ailawadi, G., Kron, I. (eds) Catheter Based Valve and Aortic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3432-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3432-4_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3430-0
Online ISBN: 978-1-4939-3432-4
eBook Packages: MedicineMedicine (R0)